Results 21 to 30 of about 306 (179)
INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS [PDF]
Рациональная фармакотерапия в кардиологии, 2015 Indications for myocardial cytoprotector, trimetazidine, in patients with ischemic heart disease are analyzed and justified according to evidence based medicine.
Zh. M. Sizova
doaj +4 more sources
New strategy for gastrointestinal protection based on gaseous mediators application [PDF]
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2016 The aim of review. To assess protective mechanisms and efficacy of gaseous mediators based antiinflammatory therapy. Key points. Nowadays there are no reasonable and effective methods of prevention and treatment of NSAID-induced intestinal lesions.
O. N. Sulaieva, J. L. Wallace
doaj +2 more sources
Intestinal barrier and dermatological diseases
Лечащий Врач, 2021 The purpose of the review is to analyze the literature data on the relationship between intestinal microbiocenosis disorders and skin diseases, as well as the effect of diet on the skin condition and features of the course of certain dermatological ...
V. A. Okhlopkov +4 more
doaj +2 more sources
CYTOPROTECTIVE EFFECT OF MELDONIUM ON CARDIOMYOCYTE [PDF]
Arta Medica, 2023 Background. The use of myocardial cytoprotectors (meldonium) in patients with exertional angina is a scientific-practical dilemma. Material and methods. An open randomized clinical trial was conducted involving 160 patients with chronic heart failure (
Olga Chetruș
doaj +2 more sources
Priming Low-Dose Gamma Irradiation Increases Cellular Radioadaptation Response through the Induction of Hsp70 and SOD2 [PDF]
Atom Indonesia, 2021 Exposure to low-dose radiation has been demonstrated to stimulate increased cell protection when receiving subsequent challenge dose in what is known as radioadaptation response.
S. Supriyadi
doaj +5 more sources
COMPARATIVE EFFECTIVENESS OF CARDIOCYTE PROTECTORS IN COMPLEX MANAGEMENT OF ARTERIAL HYPERTENSION
Российский кардиологический журнал, 2009 The study investigated the effects of cardiocyte protectors, mexicor and mildronate, in combination with ACE inhibitors, on blood levels of lipid peroxidation products, vascular endothelial function, circadian profile of blood pressure, and left ...
F. E. Khlebodarov +2 more
doaj +1 more source
Secondary prevention effectiveness in patients with stable angina [PDF]
Кардиоваскулярная терапия и профилактика, 2010 Aim. To assess the effectiveness of pharmaceutical secondary prevention in ambulatory patients with stable angina (SA), in the real-worl clinical settings. Material and methods.
Rasim Kutlu, T. M. Murataliev
doaj +1 more source
Российский кардиологический журнал, 2009 The study compared the effects of cardiocytoprotectors (mildronate, trimetazidine) on endothelial function, physical stress tolerability, and circadian blood pressure (BP) profile in patients with arterial hypertension (AH; n=60) and stable angina (n=82),
F. E. Khlebodarov +2 more
doaj +1 more source
Acta Biomedica ScientificaThe aim of this study was to determine the possibility of studying the nature of the influence of cardiocytoprotectors on energy metabolism in cardiomyocytes using a model of human peripheral blood leukocytes.Materials and methods. Sixty Wistar rats were
A. L. Khokhlov +6 more
doaj +2 more sources
Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide [PDF]
Basic and Clinical Andrology, 2019 Mário Sousa, Ana Rabaça, Rosália Sá
exaly +2 more sources